ZYBTNasdaqPharmaceutical Preparations
Zhengye Biotechnology Holding Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026
$1.45+0.05 (+3.57%)
Close on Oct 19, 2026
SEC filings
14 of Zhengye Biotechnology's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 6-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 6-K | Jul 21, 2026 | Jul 21, 2026 | SEC EDGAR |
| Current report | 6-K | Jun 4, 2026 | Jun 4, 2026 | SEC EDGAR |
| Annual report | 20-F | Dec 31, 2025 | Apr 28, 2026 | SEC EDGAR |
| Current report | 6-K | Mar 24, 2026 | Mar 25, 2026 | SEC EDGAR |
| Current report | 6-K | Feb 27, 2026 | Mar 2, 2026 | SEC EDGAR |
| Current report | 6-K | Feb 23, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 6-K | Jun 30, 2025 | Dec 12, 2025 | SEC EDGAR |
| Annual report | 20-F | Dec 31, 2024 | Jul 3, 2025 | SEC EDGAR |
| Current report | 6-K | May 23, 2025 | May 23, 2025 | SEC EDGAR |
| Current report | 6-K | Apr 2, 2025 | Apr 3, 2025 | SEC EDGAR |
| Current report | 6-K | Mar 6, 2025 | Mar 6, 2025 | SEC EDGAR |
| Current report | 6-K | Jan 14, 2025 | Jan 14, 2025 | SEC EDGAR |
| Current report | 6-K | Jan 8, 2025 | Jan 8, 2025 | SEC EDGAR |